Scopus Eşleşmesi Bulundu
0
Atıf
🔓
Açık Erişim
Özet
Epilepsy is a worldwide health issue associated with cardiac-related conditions and Sudden Unexpected Death in Epilepsy (SUDEP). The pathophysiology of SUDEP involves structural fibrosis of the myocardium, a calcium imbalance, and dysfunction of the autonomic nervous system. The objective of this investigation was to examine cardiac damage resulting from epilepsy triggered by the Pentylenetetrazol (PTZ) kindling rat model at a dosage of 35 mg/kg administered intraperitoneally, and to assess the therapeutic benefits of Resveratrol (RSV) at a dosage of 5 mg/kg. Cardiac function was evaluated using isolated papillary muscle recordings. Damage to the structure was assessed by Sirius Red staining and general tissue morphology. Molecular analyses encompassed qPCR (SERCA2a, CACNA1G, HCN2, CAS3/9) and immunofluorescence (SIRT1, Caspase-3, S100α) in conjunction with the total Ca2⁺ content. PTZ kindling enhanced seizure severity and overall spike number on ECoG. Functionally, contractile force (CF), contractile power (AUC), and contraction/relaxation velocities (± dF/dtmax) were decreased in the PTZ group compared to the Sham group at 3, 4, and 5 Hz frequencies. Contraction duration (CT) was significantly prolonged at 5 Hz, whereas no significant change was observed in relaxation time (RT). Histopathology revealed degeneration and substantial myocardial scarring. At a molecular level, PTZ decreased SERCA 2a mRNA expression (p < 0.0001) while increasing total calcium content (p < 0.0001) and pro-apoptotic markers (Caspase-3/9). Furthermore, the protective SIRT1 protein signal intensity was substantially reduced. RSV therapy resulted in a reduction of seizure severity by 2.54 ± 0.13 and also ameliorated cardiac function. Mechanistically, RSV recovered expression of SERCA2a (p < 0.0001), reduced fibrosis/apoptosis, and reactivated the anti-apoptotic SIRT1 pathway. These findings show that RSV ameliorates epilepsy-induced cardiac injury and has the potential to serve as an effective supportive treatment against SUDEP-related heart dysfunction by regulating calcium levels and activating anti-apoptotic pathways.
Havuzumuzdaki Atıflar 0
Bu makaleye, sistemimizdeki Scopus veritabanında bulunan 0 makale atıf yapmıştır.
Bu makaleye, kendi Scopus havuzumuzdaki başka bir makaleden atıf kaydı bulunmuyor.
Anahtar Kelimeler
YÖKSİS |
Bir kelimeye tıklayıp ilgili kaynaktaki yayınları görün.
Makale Bilgileri
Dergi
Naunyn-Schmiedeberg's Archives of Pharmacology
ISSN
0028-1298
Yıl
2026
/ 6. ay
Makale Türü
Özgün Makale
Hakemlik
Hakemli
Endeks
SCI-Expanded
JCR Quartile
Q2
Yayın Dili
Türkçe
Kapsam
Uluslararası
Toplam Yazar
7 kişi
Erişim Türü
Elektronik
Alan
Sağlık Bilimleri Temel Alanı
Biyofizik
Epilepsy,SUDEP,Heart dysfunction,Resveratrol,SIRT1,Ca2+channels
YÖKSİS Yazar Kaydı
Yazar Adı
AKGÜN ÜNAL NİLÜFER,ÜNAL ÖMER,TİRYAKİ EMRE SONER,AKKOCA AHMET,ŞİMŞEK SEDA,GÜLBAHÇE MUTLU ELİF,AYYILDIZ MUSTAFA
YÖKSİS ID
9593583